$29.110
-0.608 (-2.09%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ACAD Prediction & Forecast by Similar Chart Analysis
Alphio's ACAD stock price prediction model matches the current Acadia Pharmaceuticals Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $29.12 (+0.04%). The 1-week path is $28.87 (-0.82%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Acadia Pharmaceuticals Inc. Stock?
ACADIA Pharmaceuticals is a good buy right now due to its recent EU approval for DAYBU, which is expected to significantly boost revenues. The current price of $29.11 is below several analyst price targets, such as $38 from Deutsche Bank and $40 from Citi. Additionally, the company has a strong gross margin of 90.81% and a forward P/E ratio of 71.94, suggesting growth potential despite current volatility.
ACAD stock price ended at $29.11 on Friday, after losing -2.09%
Acadia Pharmaceuticals Inc. (ACAD) last closed at $29.11, losing -2.09%. These facts feed the 1-day and 1-week ACAD price prediction above.
Analyst Consensus
Acadia Pharmaceuticals Inc. (ACAD): 8 buy, 2 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Acadia Pharmaceuticals Inc. (ACAD) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches ACAD, ranked by similarity.
Seasonality analysis for ACAD
Historically the probability of a positive August return for ACAD is 63.49%. August offers the highest probability of a positive month at 63.49%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ACAD
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $25.24 | $29.14 | $36.02 | +0.09% |
| Sep 2026 | $26.80 | $28.30 | $28.97 | -2.80% |
| Oct 2026 | $21.38 | $22.99 | $25.36 | -21.02% |
| Nov 2026 | $22.81 | $28.51 | $30.75 | -2.05% |
| Dec 2026 | $19.57 | $21.36 | $26.83 | -26.62% |
In 2026, Acadia Pharmaceuticals Inc. (ACAD) is projected to range from $19.57 to $36.02.
Acadia Pharmaceuticals Inc. 2026 monthly forecast
In Aug 2026, Acadia Pharmaceuticals Inc. is projected to average $29.14, with a low of $25.24 and high of $36.02.
In Sep 2026, Acadia Pharmaceuticals Inc. is projected to average $28.30, with a low of $26.80 and high of $28.97.
In Oct 2026, Acadia Pharmaceuticals Inc. is projected to average $22.99, with a low of $21.38 and high of $25.36.
In Nov 2026, Acadia Pharmaceuticals Inc. is projected to average $28.51, with a low of $22.81 and high of $30.75.
In Dec 2026, Acadia Pharmaceuticals Inc. is projected to average $21.36, with a low of $19.57 and high of $26.83.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。